STK17A Antikörper (AA 45-150) (AbBy Fluor® 555)

Produktnummer ABIN894390

Dieses Anti-STK17A-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von STK17A in IF (cc) und IF (p). Geeignet für Human.

Kurzübersicht für STK17A Antikörper (AA 45-150) (AbBy Fluor® 555) (ABIN894390)

Target: STK17A (serine/threonine Kinase 17a (STK17A))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser STK17A Antikörper ist konjugiert mit AbBy Fluor® 555

Applikation: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Produktdetails anti-STK17A Antikörper (AbBy Fluor® 555)

Bindungsspezifität: AA 45-150

Homologie: Human,Mouse,Rat,Chicken,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human DRAK1/STK17A

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu STK17A

Target: STK17A (serine/threonine Kinase 17a (STK17A))

Andere Bezeichnung: STK17A

Hintergrund:

Synonyms: DAP kinase-related apoptosis-inducing protein kinase 1, death-associated protein kinase-related 1, EC 2.7.11.1, Serine / threonine kinase 17a death associated protein kinase related 1, Serine/threonine kinase 17a, Serine/threonine protein kinase 17a, STK17 A, STK17A, ST17A_HUMAN.

Background: DRAK1 (DAP kinase-related apoptosis-inducing protein kinase 1) is a novel member of the ser/thr protein kinase family, which mediate apoptosis through their catalytic activities. The full-length cDNA encodes a deduced 414-amino acid protein with a molecular mass of 46.56 kD. DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. DRAK1 messenger RNA appears to be ubiquitously expressed in human tissues. Overexpression of DRAK1 induces apoptosis. It has been shown in vitro that DRAK1 is capable of autophosphorylation and of phosphorylating the myosin light chain as an exogenous substrate, and that the noncatalytic C terminus is crucial for full kinase activity.

Gen-ID: 9263